A detailed history of Sara Bay Financial transactions in Johnson & Johnson stock. As of the latest transaction made, Sara Bay Financial holds 3,031 shares of JNJ stock, worth $479,625. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,031
Previous 2,971 2.02%
Holding current value
$479,625
Previous $434 Million 13.12%
% of portfolio
0.18%
Previous 0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$145.48 - $167.38 $8,728 - $10,042
60 Added 2.02%
3,031 $491 Million
Q2 2024

Jul 19, 2024

BUY
$144.38 - $157.78 $34,651 - $37,867
240 Added 8.79%
2,971 $434 Million
Q3 2023

Oct 13, 2023

BUY
$155.75 - $174.48 $32,551 - $36,466
209 Added 8.29%
2,731 $425 Million
Q1 2023

Apr 14, 2023

SELL
$151.05 - $180.26 $83,228 - $99,323
-551 Reduced 17.93%
2,522 $391 Million
Q4 2022

Jan 11, 2023

SELL
$160.2 - $179.79 $7,208 - $8,090
-45 Reduced 1.44%
3,073 $543 Million
Q3 2022

Oct 18, 2022

BUY
$161.33 - $179.52 $503,026 - $559,743
3,118 New
3,118 $509 Million
Q2 2022

Jul 12, 2022

SELL
$168.19 - $186.01 $512,138 - $566,400
-3,045 Closed
0 $0
Q1 2022

Apr 12, 2022

SELL
$158.14 - $179.59 $35,739 - $40,587
-226 Reduced 6.91%
3,045 $540 Million
Q4 2021

Jan 14, 2022

BUY
$155.93 - $173.01 $50,209 - $55,709
322 Added 10.92%
3,271 $560 Million
Q3 2021

Oct 08, 2021

SELL
$161.5 - $179.47 $14,212 - $15,793
-88 Reduced 2.9%
2,949 $476 Million
Q2 2021

Jul 16, 2021

BUY
$159.48 - $171.07 $19,456 - $20,870
122 Added 4.19%
3,037 $499 Million
Q1 2021

Apr 14, 2021

BUY
$153.07 - $170.48 $20,664 - $23,014
135 Added 4.86%
2,915 $479 Million
Q4 2020

Jan 15, 2021

SELL
$137.11 - $157.38 $5,621 - $6,452
-41 Reduced 1.45%
2,780 $438 Million
Q3 2020

Oct 07, 2020

SELL
$140.38 - $153.83 $70,190 - $76,915
-500 Reduced 15.06%
2,821 $420 Million
Q2 2020

Jul 21, 2020

BUY
$128.81 - $155.51 $427,778 - $516,448
3,321 New
3,321 $468 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $414B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sara Bay Financial Portfolio

Follow Sara Bay Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sara Bay Financial, based on Form 13F filings with the SEC.

News

Stay updated on Sara Bay Financial with notifications on news.